Emerging and future therapies for the treatment of bone loss associated with chronic inflammation

ISSN： 1568-5608

Source： Inflammopharmacology, Vol.14, Iss.5-6, 2006-12, pp. : 193-197

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging therapies for the treatment of chronic Philadelphia chromosome-negative myeloproliferative neoplasm-associated myelofibrosis

By Gowin Krisstina Mesa Ruben

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 12, 2013-12 ,pp. : 1603-1611

Informa Healthcare

Access to resources Recommend Favorite

Targeting systemic inflammation: novel therapies for the treatment of chronic obstructive pulmonary disease

By Cazzola Mario Ciaprini Chiara Page Clive P Matera Maria G

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 10, 2007-10 ,pp. : 1273-1286

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for the management of cancer treatment induced bone loss

By Bertoldo Francesco Pancheri Serena Zenari Sonia Boldini Stefania

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 2, 2010-06 ,pp. : 323-342

Informa Healthcare

Access to resources Recommend Favorite

Emerging therapies in metastatic bone pain

By Coluzzi Flaminia Mandatori Ilenia Mattia Consalvo

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 3, 2011-09 ,pp. : 441-458

Informa Healthcare

Access to resources Recommend Favorite

Emerging Therapies in Chronic Myeloid Leukemia

Current Cancer Drug Targets, Vol. 12, Iss. 5, 2012-05 ,pp. : 458-470

Bentham Science Publishers

Access to resources Recommend Favorite